Suppr超能文献

[1994年至2001年中国重症监护病房分离的非发酵革兰阴性杆菌的耐药性变化]

[Changes of antimicrobial resistance among nonfermenting gram-negative bacilli isolated from intensive care units from 1994 to 2001 in China].

作者信息

Wang Hui, Chen Min-Jun

机构信息

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China.

出版信息

Zhonghua Yi Xue Za Zhi. 2003 Mar 10;83(5):385-90.

Abstract

OBJECTIVE

To investigate the antimicrobial resistance among nonfermenting gram-negative bacilli isolated from intensive care units (ICUs) during the past 7 years in China.

METHODS

From 1994 to 2001, the minimal inhibitory concentrations (MICs) of imipenem and other ten antibiotics for 4450 strains of nosocomial nonfermenting bacteria isolated from the ICUs of 32 hospitals in China were determined by E test. WHONET-5 software was used to analyze the data.

RESULTS

The most predominant pathogens were Pseudomonas aeruginosa (46.9%), Acinetobacter spp. (31.0%), and Stenotrophomonas maltophilia (9.2%). The susceptibility rates of these nonfermenting gram-negative bacilli to cefoperazone/sulbactam, imipenem, ceftazidime, piperacillin/tazobactam, amikacin, cefepime, and ciprofloxacin were 78.6%, 77.0%, 70.1%, 69.5%, 69.9%, 63.0%, and 59.1% respectively. Imipenem and cefoperazone/sulbactam were the most active agents against nonfermenting bacilli other than S.maltophilia and Burkholderia cepacia with susceptible rates 84.2% and 77.4% respectively. From 1994 to 2001, the activity of these 11 antibiotics against Pseudomonas aeruginosa decreased; the susceptibility rates of the nonfermenting gram-negative bacilli to imipenem, ceftazidime, amikacin, cefoperazone/sulbactam, cefepime, and piperacillin/tazobactam ranged from 70.0% to 83.0%. The susceptibility rate of Acinetobacter spp. to imipenem was 95.0% and remained unchanged for years. The susceptibility rate to cefoperazone/sulbactam came second, however, it was decreased from 88.0% in 1996 to 69.0% in 2001. The susceptibility rates to ceftazidime, cefepime, piperacillin/tazobactam, ticarcillin/clavulanic acid, gentamicin, and ciprofloxacin ranged from 45% to 58%. The susceptibility of Stenotrophomonas maltophilia was the highest to cefoperazone/sulbactam, ceftazidime, and ticarcillin/clavulanic acid (78% approximately 85%). Cefoperazone/sulbactam, piperacillin/tazobactam, and imipenem inhibited 80% of Alcaligenes spp. Only cefoperazone/sulbactam and piperacillin/tazobactam inhibited 70% of the strains of Flavobacterium spp; and 73% approximately 86% of Burkholderia cepacia were susceptible to cefoperazone/sulbactam, piperacillin/tazobactam, ceftazidime, and cefepime.

CONCLUSION

In recent 7 years, the antimicrobial resistance among nonfermenting gram-negative bacilli has increased in China. Antibiotics policy is urgently needed in order to delay the resistance development.

摘要

目的

调查过去7年中国重症监护病房(ICU)分离出的非发酵革兰阴性杆菌的耐药情况。

方法

1994年至2001年,采用E试验法测定了中国32家医院ICU分离出的4450株医院内非发酵菌对亚胺培南及其他10种抗生素的最低抑菌浓度(MIC)。使用WHONET-5软件进行数据分析。

结果

最主要的病原菌是铜绿假单胞菌(46.9%)、不动杆菌属(31.0%)和嗜麦芽窄食单胞菌(9.2%)。这些非发酵革兰阴性杆菌对头孢哌酮/舒巴坦、亚胺培南、头孢他啶、哌拉西林/他唑巴坦、阿米卡星、头孢吡肟和环丙沙星的敏感率分别为78.6%、77.0%、70.1%、69.5%、69.9%、63.0%和59.1%。亚胺培南和头孢哌酮/舒巴坦是除嗜麦芽窄食单胞菌和洋葱伯克霍尔德菌外对非发酵杆菌活性最强的药物,敏感率分别为84.2%和77.4%。1994年至2001年,这11种抗生素对铜绿假单胞菌的活性降低;非发酵革兰阴性杆菌对亚胺培南、头孢他啶、阿米卡星、头孢哌酮/舒巴坦、头孢吡肟和哌拉西林/他唑巴坦的敏感率在70.0%至83.0%之间。不动杆菌属对亚胺培南的敏感率为95.0%,多年来保持不变。对头孢哌酮/舒巴坦的敏感率居第二位,然而,从1996年的88.0%降至2001年的69.0%。对头孢他啶、头孢吡肟、哌拉西林/他唑巴坦、替卡西林/克拉维酸、庆大霉素和环丙沙星的敏感率在45%至58%之间。嗜麦芽窄食单胞菌对头孢哌酮/舒巴坦、头孢他啶和替卡西林/克拉维酸的敏感性最高(约78%至85%)。头孢哌酮/舒巴坦、哌拉西林/他唑巴坦和亚胺培南对产碱杆菌属的抑制率为80%。只有头孢哌酮/舒巴坦和哌拉西林/他唑巴坦对黄杆菌属菌株的抑制率为70%;约有73%至86%的洋葱伯克霍尔德菌对头孢哌酮/舒巴坦、哌拉西林/他唑巴坦、头孢他啶和头孢吡肟敏感。

结论

近7年来,中国非发酵革兰阴性杆菌的耐药性有所增加。迫切需要制定抗生素政策以延缓耐药性的发展。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验